Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative inflammation and immunology (“I&I”) biological products, has announced successful preclinical trial results of its innovative anti–IL–17 VHH antibody (“NanoAb”). The trial evaluated Scinai’s NanoAbs as a local treatment for the large and underserved population of mild to moderate plaque psoriasis. The study…
Turbo Energy (NASDAQ: TURB), a Valencia-based company specializing in photovoltaic energy storage solutions, today announced that Movistar has launched Turbo Energy’s GoSolar offering for sale this week through Movistar’s energy branch, Solar360. A telecommunications leader in Spain and Latin America, Movistar has been recognized as one of the world’s top 500 most valuable companies in…
Turbo Energy (NASDAQ: TURB), a Valencia-based company specializing in photovoltaic energy storage solutions, today announced that Movistar has launched Turbo Energy’s GoSolar offering for sale this week through Movistar’s energy branch, Solar360. A telecommunications leader in Spain and Latin America, Movistar has been recognized as one of the world’s top 500 most valuable companies in…
Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative inflammation and immunology (“I&I”) biological products, is announcing the publication of a peer-reviewed article regarding NanoAbs. The article reports on data that supports the use of Scinai’s aerosolized NanoAbs as a platform for the treatment of hyperinflammatory viral diseases, which addresses significant…
Clene (NASDAQ: CLNN), together with its wholly owned subsidiary Clene Nanomedicine Inc., recently provided operating highlights for its amyotrophic lateral sclerosis (“ALS”) clinical program. “In August, Clene reported a 24-month long-term data cut from the open-label extension (‘OLE’) of the RESCUE-ALS study as of July 2023, which showed a significant median survival benefit of 19.3…
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has filed a spoofing complaint in the U.S. District Court for the Southern District of New York. The complaint, filed on Dec. 6, 2023, alleges that UBS Securities LLC, IMC Financial Markets and Clear Street Markets LLC engaged in a scheme using spoofing to manipulate…
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is planning to submit an Investigational New Drug (“IND”) application with the U.S. Food and Drug Administration (“FDA”) in the next 45 days. The application is for the company’s planned U.S. phase 1b Hypertension Clinical Trial. The filing had been delayed for necessary documentation…
Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) will be featured in an upcoming BTV – Business Television interview. The episode is scheduled to air on FOX Business News at 5:30 p.m. ET on Dec. 10, 2023. In the segment, “BTV highlights the company’s significant progress in its innovative silver-tin polymetallic venture in Bolivia. With…
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced its filing of a complaint in the United States District Court for the Southern District of New York alleging that UBS Securities, LLC, IMC Financial Markets and Clear Street Markets, LLC (the “Defendants”) engaged in a market manipulation scheme that violated Section 10(b)…
PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, has released a fireside chat video with CEO and chair Howard Weisman. During the company update video, Weisman outlines the company’s recent achievement and reiterates PaxMedica’s focus on developing groundbreaking therapies and transformative solutions. Specifically, Weisman provided a summary of the company’s…
CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company focused on developing innovative therapies for central nervous system disorders, specifically aggressive brain cancers. In September, the company announced that 200 out of 243 expected patients had been enrolled in its ongoing study evaluating the effectiveness of Berubicin for recurrent glioblastoma (“GBM”), a highly aggressive and incurable…
Correlate (OTCQB: CIPI), a company at the forefront of the clean distributed energy revolution, was featured in a comprehensive research report by Harbinger Research, LLC. Dated Oct. 31, 2023, the piece sheds light on Correlate, underscoring its potential in an industry ripe for growth and innovation. “As the global commitment to combatting climate change strengthens,…
Safety Shot (NASDAQ: SHOT), makers of the first patented beverage on Earth that helps people feel better faster by reducing blood alcohol content and boosting clarity, is reporting on its newly filed lawsuit against Capybara Research. According to the update, the company filed a federal lawsuit in the U.S. District Court for the Southern District of…
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has delivered its All-Electric Class 3 EV, the Mullen THREE, to the Randy Marion Automotive Group (“RMA”) in North Carolina. Mullen’s retail dealership partner, RMA is one of the largest commercial fleet dealers in the United States. The Mullen THREE is a low-cab forward chassis…
SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, today announced that its ContraPest(R) products have been registered for sale and immediate use in Puerto Rico. The first and only EPA-registered rat contraceptive impacting both male and female rats, ContraPest fits seamlessly into all integrated pest management programs, significantly improving the…
Safety Shot (NASDAQ: SHOT), a wellness and functional beverage company, announced that its flagship product, Safety Shot, sold out within hours after being released on Amazon.com. The scientifically formulated beverage is the first patented beverage that helps consumers feel better faster by reducing blood alcohol content and boosting clarity. The announcement noted that the product…
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that it has hired Mark R. Basile, Esq. and his law firm, The Basile Law Firm P.C., to assist the company in reviewing its current fundings and to make recommendations in developing its floorplan for future fundings. “Mullen is committed to full transparency…
Turbo Energy (NASDAQ: TURB) designs, develops and distributes equipment for the generation, management and storage of photovoltaic energy in Spain, Europe and internationally. “Turbo Energy’s products include lithium-ion batteries and inverters. Additionally, the company recently launched its flagship product, the Sunbox, an all-in-one device that integrates most of the equipment required for a residential photovoltaic…
Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, in October announced topline results from its phase 2a CLEAR MIND trial, investigating Lomecel-B(TM) for the treatment of mild Alzheimer’s disease (“AD”). “Lomecel-B(TM) is an allogeneic medicinal signaling cell (‘MSC’). MSCs appear to possess anti-inflammatory, pro-vascular and pro-regenerative properties.…